REGENXBIO, Inc. (RGNX)
5.69
-0.03
(-0.52%)
USD |
NASDAQ |
May 18, 13:07
REGENXBIO Profit Margin (Quarterly) : -1.41K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 45.29% |
| Ocugen, Inc. | -1.25K% |
| Replimune Group, Inc. | -- |
| AbbVie, Inc. | 4.58% |
| Krystal Biotech, Inc. | 48.07% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -187.6% |
| Return on Assets | -60.62% |
| Return on Invested Capital | -74.16% |
| Gross Profit Margin (Quarterly) | -133.6% |
| Operating Margin (Quarterly) | -1.30K% |
| Return on Net Operating Assets | -153.9% |